Literature DB >> 20482240

Regional lymphomatoid papulosis in a child--treatment with a UVB phototherapy handpiece.

Joana Dias Coelho1, Ana Afonso, Ana Barata Feio.   

Abstract

Lymphomatoid papulosis (LyP) is a rare skin lymphoproliferative disorder that has been reported only rarely in children. It is included in the World Health Organization classification of cutaneous lymphomas. We report a case of LyP in a 13-year-old Caucasian girl who presented with a 6-month history of recurrent papular lesions on the left upper arm. Histopathologic examination showed a diffuse cellular infiltration of small and medium-sized T lymphocytes CD30+ in the superficial dermis. Treatment was started using a UVB phototherapy handpiece (twice weekly), with resolution of the lesions after 6 weeks of treatment. There was a relapse after 9 months with a good response after six more sessions of treatment. The patient is in good health without lesions after 12 months of follow-up.

Entities:  

Mesh:

Year:  2010        PMID: 20482240     DOI: 10.3109/14764172.2010.487911

Source DB:  PubMed          Journal:  J Cosmet Laser Ther        ISSN: 1476-4172            Impact factor:   2.247


  2 in total

Review 1.  EORTC, ISCL, and USCLC consensus recommendations for the treatment of primary cutaneous CD30-positive lymphoproliferative disorders: lymphomatoid papulosis and primary cutaneous anaplastic large-cell lymphoma.

Authors:  Werner Kempf; Katrin Pfaltz; Maarten H Vermeer; Antonio Cozzio; Pablo L Ortiz-Romero; Martine Bagot; Elise Olsen; Youn H Kim; Reinhard Dummer; Nicola Pimpinelli; Sean Whittaker; Emmilia Hodak; Lorenzo Cerroni; Emilio Berti; Steve Horwitz; H Miles Prince; Joan Guitart; Teresa Estrach; José A Sanches; Madeleine Duvic; Annamari Ranki; Brigitte Dreno; Sonja Ostheeren-Michaelis; Robert Knobler; Gary Wood; Rein Willemze
Journal:  Blood       Date:  2011-08-12       Impact factor: 22.113

2.  Lymphomatoid papulosis misdiagnosed as pityriasis lichenoides et varioliformis acuta: Two case reports and a literature review.

Authors:  Yan Zheng; Jinjing Jia; Qiong Tian; Xinyu Dong; Xin Wang; Zhaoxia Ying; Shengxiang Xiao; Wensheng Li
Journal:  Exp Ther Med       Date:  2014-10-07       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.